Skip to main content
Menu
Main navigation
About BRI
Leadership
Faculty
Administrative Leaders
Contact Us
Diversity, Equity and Inclusion
Our Research
Centers of Discovery
Fundamental Immunology
Translational Immunology
Interventional Immunology
Systems Immunology
Bioinformatics at BRI
Labs
Biorepositories
Be a Part of BRI Research
Clinical Research
Allergies & Asthma Clinical Research
Core Labs
Cell And Tissue Analysis Group
Genomics Core
Human Immunophenotyping Core
Tetramer Core
Immune Tolerance Network
Scientific Publications
Scientific Symposium
Collaborations with BRI
Opportunities for Collaboration
Technology Available for Licensing
News
Press Releases
Support our Research
Donate Now
BRI Events
Utility Menu
Immunology Learning Center
Autoimmune Life Blog
Careers
Clinical Research at VMMC
Search
BRI News
Learn about BRI's world-renowned advancements in autoimmune disease research.
Sections
Press Releases
April 3, 2024
Benaroya Research Institute Awarded $4.1 Million National Institutes of Health Grant to Study Regulatory T Cells’ Function in Immune System Homeostasis
Read More
March 25, 2024
Runner Completes “2 Half Marathons, 2 Coasts, 2 Days” in support of BRI and Autoimmune Disease Awareness
Read More
January 31, 2024
LITAF Protects Against Pore-Forming Protein–Induced Cell Death by Promoting Membrane Repair: Interview with Drs. Stefani & Lacy-Hulbert
Read More ➡
January 25, 2024
Benaroya Research Institute’s Steven F. Ziegler, PhD, Named 2024 Distinguished Fellow by the American Association of Immunologists
Read More
January 18, 2024
Benaroya Research Institute President Jane Buckner, MD, Receives 2024 American Association of Immunologists’ Steinman Award for Human Immunology Research
Read More
January 5, 2024
Protein LITAF Provides Resistance to Pore-Forming Toxin-Induced Cell Death
Read More
December 26, 2023
Science in Seattle: A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab
Read the publication ➡
October 25, 2023
Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award
Read More
October 9, 2023
BRI Investigator Alice Long, PhD, Interviewed on the Immunology Podcast
Read More
October 3, 2023
Benaroya Research Institute Immunologist John Ray Receives 2023 NIH Director’s New Innovator Award
Read More
October 2, 2023
Benaroya Research Institute Receives $9 Million in Funding, With a Focus on Down Syndrome Research
Read More
September 25, 2023
BRI Investigators Jane Buckner, MD, and Carmen Mikacenic, MD, Interviewed on the Arthritis Life Podcast
Read More
September 20, 2023
Researchers zoom in on new ways to view biomolecules in pathogens
Read More ➡
August 23, 2023
Vlad V. Simianu, MD, MPH, Appointed as Medical Director of Benaroya Research Institute’s Clinical Research Program
Read More
July 28, 2023
Invent@SC’s Future Biotech Leaders, a post-doctoral training program developed in partnership with BRI, FHCRC and UW
Read more ➡
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Next
Last page
Last
Close
Group
Search
Search